viracept
roche registration ltd. - nelfinavir - hiv-infeksjoner - antivirale midler til systemisk bruk - viracept er indisert ved antiretroviral kombinationsbehandling av hiv-1-infiserte voksne, ungdom og barn på tre år og eldre. i protease-inhibitor (pi)-erfarne pasienter, valg av nelfinavir bør være basert på individuelle viral motstand testing og behandling historie.
volibris
glaxosmithkline (ireland) limited - ambrisentan - hypertensjon, pulmonal - antihypertensiva, - volibris is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii to iii, including use in combination treatment (see section 5. efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease. volibris is indicated for treatment of pah in adolescents and children (aged 8 to less than 18 years) of who functional class (fc) ii to iii including use in combination treatment. efficacy has been shown in ipah, familial, corrected congenital and in pah associated with connective tissue disease (see section 5.
bosentan accord 125 mg
accord healthcare b.v. - bosentanmonohydrat - tablett, filmdrasjert - 125 mg
bosentan accord 62.5 mg
accord healthcare b.v. - bosentanmonohydrat - tablett, filmdrasjert - 62.5 mg
bosentan sandoz 125 mg
sandoz - københavn - bosentanmonohydrat - tablett, filmdrasjert - 125 mg
bosentan sandoz 62.5 mg
sandoz - københavn - bosentanmonohydrat - tablett, filmdrasjert - 62.5 mg
clarithromycin teva 500 mg
teva sweden ab - klaritromycin - tablett, filmdrasjert - 500 mg
clarithromycin teva 250 mg
teva sweden ab - klaritromycin - tablett, filmdrasjert - 250 mg
carduran cr 4 mg
upjohn eesv - doksazosinmesilat - depottablett - 4 mg
carduran cr 8 mg
upjohn eesv - doksazosinmesilat - depottablett - 8 mg